<DOC>
	<DOCNO>NCT01541423</DOCNO>
	<brief_summary>This observational ( non-interventional ) study conduct characterize safety use CINRYZE routine clinical practice administer ( 1 ) routine prevention angioedema attack , ( 2 ) pre-procedure prevention angioedema attack , and/or ( 3 ) treatment angioedema attack .</brief_summary>
	<brief_title>A European Post-Authorisation Observational Study Of Patients With Hereditary Angioedema</brief_title>
	<detailed_description />
	<mesh_term>Angioedema</mesh_term>
	<mesh_term>Angioedemas , Hereditary</mesh_term>
	<criteria>Inclusion Criteria All patient must : Have diagnosis HAE receive CINRYZE prevention treatment angioedema attack Provide write informed consent/assent compliance applicable countryspecific local regulation Exclusion Criteria All patient must : Be receive CINRYZE investigational study Be receive another HAE therapy part clinical trial</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>